Mercer Global Advisors
IMGN

Mercer Global Advisors’s Immunogen Inc IMGN Stock Holding History

Mercer Global Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,047
Closed -$209K – 2178
2023
Q4 		$209K Buy
+7,047
New +$140K ﹤0.01% 1818

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mercer Global Advisors's IMGN Position: Q1 2024 in Review

Mercer Global Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 7,047 shares — an estimated $209K sold.

Mercer Global Advisors first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $209K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Mercer Global Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Mercer Global Advisors sold 7,047 Immunogen Inc shares in Q1 2024, an estimated $209K.
  • Mercer Global Advisors first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Mercer Global Advisors's Immunogen Inc position peaked at $209K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Mercer Global Advisors's 13F filing for Q1 2024, filed 15 May 2024.